Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
71 hedge funds and large institutions have $274M invested in Derma Sciences, Inc. Common Stock (DE) in 2014 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 36 increasing their positions, 6 reducing their positions, and 8 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 6
200% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 8
97% more capital invested
Capital invested by funds: $140M → $274M (+$135M)
29% more funds holding
Funds holding: 55 → 71 (+16)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$13.3M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$12.6M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$12M |
| 4 |
CCM
Consonance Capital Management
New York
|
+$11.5M |
| 5 |
BC
Broadfin Capital
New York
|
+$10.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.48M |
| 2 |
First Manhattan
New York
|
-$5.41M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$5.38M |
| 4 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$1.19M |
| 5 |
TS
Third Security
Radford,
Virginia
|
-$852K |
DSCI Hedge Fund Activity: Q1 2014 in Review
71 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q1 2014, worth a combined $274M — up 97% from $140M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new DSCI positions and 8 closed out — a net gain of 16 holders — while 36 added to existing stakes and 6 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $13.3M. The largest seller was RA Capital Management, cutting an estimated $8.48M.
- 71 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q1 2014, up from 55 in Q4 2013.
- Funds reported $274M of Derma Sciences, Inc. Common Stock (DE) stock for Q1 2014, up 97% quarter-over-quarter.
- 24 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q1 2014 and 8 closed out, a net change of +16 holders.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q1 2014 was JP Morgan Chase, an estimated $13.3M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q1 2014 was RA Capital Management, an estimated $8.48M sold.
Based on aggregated 13F filings for Q1 2014.